[Effects of immunosuppressor and cytostatic agents on the extracellular matrix production during experimental neuropathies].
Krivoshchapov
L G
LG
Pal'tseva
E M
EM
D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology*; D002908:Chronic Disease; D003520:Cyclophosphamide / Q000494:pharmacology; D016572:Cyclosporine / Q000494:pharmacology; D005109:Extracellular Matrix / Q000378:metabolism*; D005921:Glomerulonephritis / Q000276:immunology / Q000378:metabolism*; D007166:Immunosuppressive Agents / Q000494:pharmacology*; D008775:Methylprednisolone / Q000494:pharmacology; D009401:Nephrosis / Q000139:chemically induced / Q000378:metabolism; D011692:Puromycin Aminonucleoside / Q000633:toxicity; D051381:Rats; D017208:Rats, Wistar
D000970:Antineoplastic Agents; D007166:Immunosuppressive Agents; D011692:Puromycin Aminonucleoside; D016572:Cyclosporine; D003520:Cyclophosphamide; D008775:Methylprednisolone